Dose of adenoviral vectors expressing interleukin-2 plays an important role in combined gene therapy with cytosine deaminase/5-fluorocytosine: preclinical consideration.
about
Adenovirus-mediated interleukin-12 gene transfer combined with cytosine deaminase followed by 5-fluorocytosine treatment exerts potent antitumor activity in Renca tumor-bearing mice.Cytotoxic effect of co-expression of human hepatitis A virus 3C protease and bifunctional suicide protein FCU1 genes in a bicistronic vector.Sonoporation delivery of interleukin-27 gene therapy efficiently reduces prostate tumor cell growth in vivo.
P2860
Dose of adenoviral vectors expressing interleukin-2 plays an important role in combined gene therapy with cytosine deaminase/5-fluorocytosine: preclinical consideration.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Dose of adenoviral vectors exp ...... ne: preclinical consideration.
@en
Dose of adenoviral vectors exp ...... ne: preclinical consideration.
@nl
type
label
Dose of adenoviral vectors exp ...... ne: preclinical consideration.
@en
Dose of adenoviral vectors exp ...... ne: preclinical consideration.
@nl
prefLabel
Dose of adenoviral vectors exp ...... ne: preclinical consideration.
@en
Dose of adenoviral vectors exp ...... ne: preclinical consideration.
@nl
P2093
P2860
P921
P1476
Dose of adenoviral vectors exp ...... ne: preclinical consideration.
@en
P2093
Hirofumi Hamada
Hiroki Yamaue
Hiroshi Terasawa
Kentaro Ueda
Makoto Iwahashi
Mikihito Nakamori
Takuya Tsunoda
P2860
P304
P356
10.1111/J.1349-7006.2002.TB01310.X
P577
2002-06-01T00:00:00Z